Literature DB >> 18333185

Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.

Dominique Delbeke1, William H Martin.   

Abstract

Entities:  

Year:  2005        PMID： 18333185      PMCID： PMC2023947          DOI： 10.1080/13651820510028909

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  84 in total

Review 1.  PET/CT scanners: a hardware approach to image fusion.

Authors:  David W Townsend; Thomas Beyer; Todd M Blodgett
Journal:  Semin Nucl Med       Date:  2003-07       Impact factor: 4.446

2.  Glucose-6-phosphatase activity in normal, pre-cancerous, and neoplastic tissues.

Authors:  G WEBER; A CANTERO
Journal:  Cancer Res       Date:  1955-02       Impact factor: 12.701

3.  Fluorine-18: a new isotope for bone scanning.

Authors:  M BLAU; W NAGLER; M A BENDER
Journal:  J Nucl Med       Date:  1962-07       Impact factor: 10.057

4.  Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma.

Authors:  M Zimny; J Fass; R Bares; U Cremerius; O Sabri; P Buechin; V Schumpelick; U Buell
Journal:  Scand J Gastroenterol       Date:  2000-08       Impact factor: 2.423

5.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.

Authors:  B Gray; G Van Hazel; M Hope; M Burton; P Moroz; J Anderson; V Gebski
Journal:  Ann Oncol       Date:  2001-12       Impact factor: 32.976

6.  Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.

Authors:  M H Whiteford; H M Whiteford; L F Yee; O A Ogunbiyi; F Dehdashti; B A Siegel; E H Birnbaum; J W Fleshman; I J Kodner; T E Read
Journal:  Dis Colon Rectum       Date:  2000-06       Impact factor: 4.585

7.  18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.

Authors:  B Nakata; Y S Chung; S Nishimura; T Nishihara; Y Sakurai; T Sawada; T Okamura; J Kawabe; H Ochi; M Sowa
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

8.  Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

Authors:  S Adams; R Baum; T Rink; P M Schumm-Dräger; K H Usadel; G Hör
Journal:  Eur J Nucl Med       Date:  1998-01

Review 9.  Nuclear medicine imaging of neuroendocrine tumours.

Authors:  E Bombardieri; M Maccauro; E De Deckere; G Savelli; A Chiti
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

Review 10.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742
View more
  10 in total

Review 1.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

3.  The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.

Authors:  Michael Sørensen; Kim Frisch; Dirk Bender; Susanne Keiding
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-07       Impact factor: 9.236

4.  Groove Pancreatitis Associated with Transient Liver Injury Mimicking Ampullary Neoplasm.

Authors:  Elrazi Awadelkarim Hamid Ali; Ahmed Emad Mahfouz; Akhnuwkh Jones; Abdelatif Abdelmola; Mohamed A Yassin
Journal:  Case Rep Gastroenterol       Date:  2020-06-02

5.  Predictive value of metabolic activity detected by pre-operative 18F FDG PET/CT in ampullary adenocarcinoma.

Authors:  Young Mok Park; Hyung Il Seo
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

Review 6.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

7.  Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass.

Authors:  Matthew E Wampole; John C Kairys; Edith P Mitchell; Martha L Ankeny; Mathew L Thakur; Eric Wickstrom
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

8.  FDG-PET/CT-based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy.

Authors:  Erkan Topkan; Cem Parlak; Ali Fuat Yapar
Journal:  Cancer Imaging       Date:  2013-10-04       Impact factor: 3.909

9.  CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer.

Authors:  Olaguoke Akinwande; Shakeeb S Ahmad; Tracy Van Meter; Brittany Schulz; Robert C G Martin
Journal:  J Oncol       Date:  2015-11-05       Impact factor: 4.375

10.  Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.

Authors:  Jacob Horsager; Kirstine Bak-Fredslund; Lars Peter Larsen; Gerda Elisabeth Villadsen; Trond Velde Bogsrud; Michael Sørensen
Journal:  EJNMMI Res       Date:  2016-06-24       Impact factor: 3.138
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.